107 related articles for article (PubMed ID: 8161669)
1. Does lansoprazole influence postprandial digestive function?
Vidon N; Dutreuil C; Scoule JC; Delchier JC
Aliment Pharmacol Ther; 1993 Dec; 7(6):629-34. PubMed ID: 8161669
[TBL] [Abstract][Full Text] [Related]
2. Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.
Berlin I; Molinier P; Duchier A; Cournot A; Durrel J; Dellatolas F; Duchier J
Eur J Clin Pharmacol; 1992; 43(2):117-9. PubMed ID: 1425865
[TBL] [Abstract][Full Text] [Related]
3. Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers.
Renou C; Carrière F; Ville E; Grandval P; Joubert-Collin M; Laugier R
Digestion; 2001; 63(4):207-13. PubMed ID: 11435719
[TBL] [Abstract][Full Text] [Related]
4. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Fuchs W; Richter G; Burkhardt F; Wolf N; Walter TA
Aliment Pharmacol Ther; 1997 Apr; 11(2):359-64. PubMed ID: 9146776
[TBL] [Abstract][Full Text] [Related]
6. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
[TBL] [Abstract][Full Text] [Related]
7. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
Brummer RJ; Geerling BJ; Stockbrügger RW
Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
[TBL] [Abstract][Full Text] [Related]
8. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
[TBL] [Abstract][Full Text] [Related]
9. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects.
Harder H; Teyssen S; Stephan F; Pfützer R; Kiel G; Fuchs W; Singer MV
Scand J Gastroenterol; 1999 Jun; 34(6):551-61. PubMed ID: 10440603
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
[TBL] [Abstract][Full Text] [Related]
11. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
Hirschowitz BI; Mohnen J; Shaw S
Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
[TBL] [Abstract][Full Text] [Related]
13. Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary, or gastric function.
Hotz J; Ho SB; Go VL; DiMagno EP
J Lab Clin Med; 1983 Mar; 101(3):488-95. PubMed ID: 6186758
[TBL] [Abstract][Full Text] [Related]
14. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects.
Fraser AG; Sawyerr AM; Hudson M; Smith MS; Pounder RE
Aliment Pharmacol Ther; 1996 Aug; 10(4):523-7. PubMed ID: 8853755
[TBL] [Abstract][Full Text] [Related]
15. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rate.
Rasmussen L; Qvist N; Oster-Jørgensen E; Rehfeld JF; Holst JJ; Pedersen SA
Scand J Gastroenterol; 1997 Sep; 32(9):900-5. PubMed ID: 9299668
[TBL] [Abstract][Full Text] [Related]
17. Proton-pump inhibition for acid-related disease.
Holt S
South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
[TBL] [Abstract][Full Text] [Related]
18. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
Tomiyama Y; Morii M; Takeguchi N
Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
[TBL] [Abstract][Full Text] [Related]
19. Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers.
Bell N; Karol MD; Sachs G; Greski-Rose P; Jennings DE; Hunt RH
Aliment Pharmacol Ther; 2001 Jan; 15(1):105-13. PubMed ID: 11136283
[TBL] [Abstract][Full Text] [Related]
20. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
Verdú EF; Fraser R; Armstrong D; Blum AL
Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
